CNC - Centene Corporation
NYSE
->
Healthcare
->
Healthcare Plans
St. Louis,
United States
Type: Equity
CNC price evolution
CNC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17605 | $17585 | $17193 | |
| Short term investments | $2609 | $2082 | $2459 | |
| Net receivables | $18281 | $16587 | $16824 | $15532 |
| Inventory | ||||
| Total current assets | $37409 | $38406 | $38448 | $32725 |
| Long term investments | $16870 | $16496 | $16286 | |
| Property, plant & equipment | $2042 | $2041 | $1988 | $2019 |
| Goodwill & intangible assets | $23313 | $23486 | $23659 | |
| Total noncurrent assets | $44731 | $44176 | $43885 | |
| Total investments | $19479 | $18578 | $18745 | |
| Total assets | $82351 | $83137 | $82624 | $84641 |
| Current liabilities | ||||
| Accounts payable | $13338 | $12232 | $12130 | $16420 |
| Deferred revenue | $597 | $681 | $715 | |
| Short long term debt | $112 | $113 | $119 | |
| Total current liabilities | $34061 | $32729 | $32784 | $36716 |
| Long term debt | $17494 | $17516 | $17887 | $17710 |
| Total noncurrent liabilities | $22951 | $22776 | $21969 | |
| Total debt | $17628 | $18000 | $17829 | |
| Total liabilities | $55044 | $55680 | $55560 | $58801 |
| Shareholders' equity | ||||
| Retained earnings | $15065 | $14352 | $13206 | $12043 |
| Other shareholder equity | -$226 | -$646 | -$630 | -$652 |
| Total shareholder equity | $27351 | $26958 | $25840 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17193 | $12074 | $13118 | $10800 |
| Short term investments | $2459 | $2321 | $1539 | $1580 |
| Net receivables | $15532 | $13272 | $12238 | $9696 |
| Inventory | ||||
| Total current assets | $32725 | $30128 | $28497 | $23393 |
| Long term investments | $16286 | $14684 | $14043 | $12853 |
| Property, plant & equipment | $2019 | $2432 | $3391 | $2774 |
| Goodwill & intangible assets | $23659 | $25723 | $27595 | $27040 |
| Total noncurrent assets | $43885 | $46742 | $49878 | $45326 |
| Total investments | $18745 | $17005 | $15582 | $14433 |
| Total assets | $84641 | $76870 | $78375 | $68719 |
| Current liabilities | ||||
| Accounts payable | $16420 | $9525 | $8493 | $7069 |
| Deferred revenue | $715 | $478 | $434 | $523 |
| Short long term debt | $119 | $82 | $267 | $97 |
| Total current liabilities | $36716 | $1716 | $25765 | $21585 |
| Long term debt | $17710 | $17938 | $18571 | $16682 |
| Total noncurrent liabilities | $21969 | $24169 | $25588 | $21172 |
| Total debt | $17829 | $18020 | $18838 | $16779 |
| Total liabilities | $58801 | $52813 | $51353 | $42757 |
| Shareholders' equity | ||||
| Retained earnings | $12043 | $9341 | $8139 | $6792 |
| Other shareholder equity | -$652 | -$1132 | $77 | $337 |
| Total shareholder equity | $25840 | $24057 | $26795 | $25773 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $42023 | $39836 | $40407 | $39460 |
| Cost of revenue | $35407 | $35762 | ||
| Gross Profit | $4035 | $4429 | $4645 | $3660 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2894 | $3218 | ||
| Total operating expenses | $3362 | $3200 | $3539 | $3803 |
| Operating income | $1229 | $1106 | ||
| Income from continuing operations | ||||
| EBIT | $1692 | $1656 | ||
| Income tax expense | $211 | $370 | $315 | -$15 |
| Interest expense | -$176 | $176 | $178 | -$183 |
| Net income | ||||
| Net income | $713 | $1146 | $1163 | $45 |
| Income (for common shares) | $1146 | $1163 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $153999 | $144547 | $125982 | $111115 |
| Cost of revenue | $127891 | $111783 | $95899 | |
| Gross Profit | $17315 | $16656 | $14199 | $15216 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $11589 | $10166 | $9867 | |
| Total operating expenses | $13856 | $15338 | $12415 | $12134 |
| Operating income | $1318 | $1784 | $3082 | |
| Income from continuing operations | ||||
| EBIT | $2627 | $2489 | $3515 | |
| Income tax expense | $899 | $760 | $477 | $979 |
| Interest expense | -$725 | $665 | $665 | $728 |
| Net income | ||||
| Net income | $2702 | $1202 | $1347 | $1808 |
| Income (for common shares) | $1202 | $1347 | $1808 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $1146 | $1163 | ||
| Operating activities | ||||
| Depreciation | $306 | $308 | ||
| Business acquisitions & disposals | $80 | $879 | ||
| Stock-based compensation | $62 | $70 | ||
| Total cash flows from operations | $2175 | -$456 | ||
| Investing activities | ||||
| Capital expenditures | -$186 | -$151 | ||
| Investments | -$1061 | $124 | ||
| Total cash flows from investing | -$1154 | -$1167 | $852 | -$1191 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$792 | -$137 | ||
| Net borrowings | -$378 | $163 | ||
| Total cash flows from financing | -$2393 | -$1171 | $23 | -$1658 |
| Effect of exchange rate | $7 | $1 | $6 | -$32 |
| Change in cash and equivalents | -$2799 | -$162 | $425 | $5122 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1202 | $1347 | $1808 | |
| Operating activities | ||||
| Depreciation | $1553 | $1476 | $1259 | |
| Business acquisitions & disposals | $1017 | -$466 | -$3583 | |
| Stock-based compensation | $234 | $203 | $281 | |
| Total cash flows from operations | $6261 | $4205 | $5503 | |
| Investing activities | ||||
| Capital expenditures | -$1004 | -$910 | -$869 | |
| Investments | -$2934 | -$1942 | -$2481 | |
| Total cash flows from investing | -$1191 | -$2921 | -$3299 | -$6955 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3026 | -$297 | -$626 | |
| Net borrowings | -$1144 | $1604 | $839 | |
| Total cash flows from financing | -$1658 | -$4197 | $1362 | $260 |
| Effect of exchange rate | -$32 | -$11 | -$11 | $18 |
| Change in cash and equivalents | $5122 | -$868 | $2257 | -$1174 |
News
Fundamentals
| Market cap | $31.95B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 510.08M |
| Revenue | $161.73B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.07B |
| Revenue Q/Q | 10.46% |
| Revenue Y/Y | 7.75% |
| P/E ratio | 10.42 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.20 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $6.01 |
|---|---|
| ROA | 3.69% |
| ROE | N/A |
| Debt/Equity | 2.28 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.10 |
| Quick ratio | N/A |